home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 02/23/26

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NASDAQ
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that management will participate in one-o...
BWAY - BrainsWay down after investment in Canadian mental care provider

2026-02-19 14:33:55 ET More on BrainsWay BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript BrainsWay Ltd. (BWAY) Analyst/Investor Day - Slideshow BrainsWay gains as Cigna removes prior authorizations for depression therapy BrainsWay to change in ADS ratio...

BWAY - BrainsWay Ltd. (NASDAQ: BWAY) is a Stock Spotlight on 2/19

2026-02-19 09:54:53 ET BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -3.96% on the day to $25.01. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the ...

BWAY - BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BrainsWay continues to activel y evaluat e similar investments in l eading North American m ental h ealth p roviders to raise awareness and e xpand a ccess to transformative care BURLINGTON, Mass. and JERUSALEM, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Brains...
BWAY - BrainsWay gains as Cigna removes prior authorizations for depression therapy

2026-02-18 08:54:36 ET More on BrainsWay BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript BrainsWay Ltd. (BWAY) Analyst/Investor Day - Slideshow BrainsWay to change in ADS ratio to 1-for-1, effective March 3 Seeking Alpha’s Quant Rating on BrainsW...

BWAY - BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent  news issued by Evern...

BWAY - BrainsWay to change in ADS ratio to 1-for-1, effective March 3

2026-02-17 07:54:45 ET More on BrainsWay BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript BrainsWay Ltd. (BWAY) Analyst/Investor Day - Slideshow Seeking Alpha’s Quant Rating on BrainsWay Historical earnings data for BrainsWay Financial inf...
BWAY - BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that its Board of Directors approved a pl...

BWAY - BrainsWay Ltd. (NASDAQ: BWAY) Sets New 52-Week High in Tuesday Session

2026-01-27 09:46:54 ET Shares of BrainsWay Ltd. (NASDAQ: BWAY) traded at a new 52-week high today and are currently trading at $23.18. So far today, approximately 54,662 shares have been exchanged, as compared to an average 30-day volume of 114.06k shares. BrainsWay Ltd. develops an...

BWAY - Buy Recommendation Issued On BWAY By H.C. Wainwright

2026-01-26 06:15:10 ET H.C. Wainwright analyst issues BUY recommendation for BWAY on January 26, 2026 11:07AM ET. The previous analyst recommendation was Buy. BWAY was trading at $23.04 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...
Previous 10 Next 10